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Prospective Analysis on the Relation
between Pain and Prostate Volume during
Transrectal Prostate Biopsy
Objective: We wanted to assess the relationship between pain and the
prostate volume during transrectal ultrasound (TRUS) guided biopsy. 
Materials and Methods: Between July and September 2006, 71 patients
scheduled for TRUS biopsy of the prostate were considered for inclusion to this
study. These patients underwent periprostatic neurovascular bundle block with
lidocaine prior to biopsy. Pain was assessed using a Visual Analogue Scale
(VAS) during periprostatic neurovascular bundle block (VAS 1), during biopsy
(VAS 2), and 20 minutes after biopsy (VAS 3). The mean pain scores were ana-
lyzed in the large prostate group (prostate volume > 40 cc) and the small prostate
group (prostate volume  40 cc). P values < 0.05 were considered significant. 
Results: The mean prostate volume was 42.2 cc (standard deviation: 8.6). The
mean pain scores of VAS 1, 2 and 3 were 4.70  1.61, 3.15  2.44 and 1.05 
1.51, respectively. In the large prostate group, the mean pains scores of VAS 1, 2
and 3 were 4.75  1.76, 3.51  2.76 and 1.29  1.70, respectively, whereas in
the small prostate group, the means pain scores were 4.66  1.46, 2.77  2.0,
and 0.80  1.26, respectively. Although there were no statistical differences of
VAS 1, the larger prostate group revealed higher pain scores of VAS 2 and 3
compared with the small prostate group (p < 0.05). 
Conclusion: Patients with larger prostate volumes tend to feel more pain dur-
ing and after TRUS guided prostate biopsy. Our findings suggest that additional
analgesic strategies may be necessary when the patients with larger prostate
undergo TRUS guided prostate biopsy. 
he diagnosis of prostate cancer depends on obtaining histologically
malignant tissue from the prostate gland by performing biopsy.
Transrectal ultrasound (TRUS) guided biopsies of the prostate are the
accepted gold standard for detecting prostate cancer. Even though a prostate biopsy is
generally considered a minor procedure that is well tolerated by most patients, a few
studies have reported that about 65 to 90% of patients complain of discomfort or pain
(1, 2). 
Several investigators have evaluated the relationship between pain during a TRUS
guided prostate biopsy procedure and the prostate volume. Although the recently
published findings have indicated that larger prostate volumes do not necessarily
increase the pain associated with the procedure (3, 4), our clinical impression, based
on experience, is that the prostate volume is certainly related to the patient’s degree of
pain during TRUS guided prostate biopsy. 
The aim of this study was to assess the relationship between pain and the prostate
volume during a TRUS guided prostate biopsy procedure.
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This prospective study was approved by our institutional
review board. All the patients gave us a signed, written
informed consent form prior to performing TRUS guided
biopsy. 
During the three month period from July to September
2006, 71 patients who satisfied the following criteria were
enrolled in this study: 1) patients with increased levels of
prostate specific antigen (PSA) with or without an
abnormal digital rectal examination; 2) patients with lesion
suspected to be malignancy on TRUS with or without an
abnormal digital rectal examination; 3) patients without a
history of warfarin treatment or a bleeding tendency or
allergy to lidocaine; 4) patients without a history of
previous TRUS guided prostate biopsy. Two radiologists
performed the prostate biopsies. All imaging was
performed using a HDI 5000 ultrasound scanner (Philips,
Bothell, WA) equipped with 9 4 MHz broadband curved
array endocavitary transducer.
For all 71 patients, a total of 8 ml of 1% lidocaine was
administered, at both basolateral aspects of the prostate,
five minutes prior to the prostate biopsies, and a 22 gauge
needle was used for this (SONORIJECT; TSK Laboratory,
Japan) (Fig. 1).
The prostate volumes were evaluated using the prolate
ellipse formula ( /6 [transverse diameter X anterior-
posterior diameter X cephalocaudal diameter]), which is
the most commonly used method of determining prostate
volumes.
After determining the prostate volume, a total of 12
systematic prostate cores, including six parasagitally
targeted biopsies and six laterally targeted biopsies
covering the base, mid zones and apexes, were obtained
from all the patients with using an 18 gauge spring loaded
biopsy gun (ACECUT; TSK Laboratory, Japan). The first
biopsy site was the left apex; this was followed by biopsy
at the left middle area, the base, the right apex, the right
middle area and the base. All the patients were observed
for at least one day after the procedure. 
During procedures, the patients were asked to score their
degree of pain with using a Visual Analogue Scale (VAS),
1) during the periprostatic neurovascular bundle block
(VAS 1), 2) during the biopsy (VAS 2), and 3) 20 minutes
after biopsy (VAS 3) (0; no pain, 10: unbearable pain). The
VAS we used had a length of 0 to 10 cm, and the patients’
assessments were converted into numeric scores. 
We divided the patients into two groups: the large
prostate group (prostate volume > 40 cc) and the small
prostate group (prostate volume  40 cc).
Statistical analysis was performed using SPSS version
11.0 (SPSS, Chicago, IL). Levene’s tests were used to
assess the equality of variances between the patients in the
two groups. Student t tests were performed for making
comparison of age, PSA levels and the pain scores at each
stage (VAS 1, 2 and 3) between the large prostate and
small prostate groups, respectively, and Fishers’ exact tests
were used to assess the difference in the cancer prevalence
between the two groups. P values < 0.05 were considered
statistically significant.
RESULTS
The mean patient age, PSA level and prevalence of
cancer were similar between the two groups (Table 1). The
mean prostate volume was 42.2 cc (standard deviation:
8.6), and the mean total prostate volumes were 52.4 cc
(range: 41.0 cc to 92.9 cc) in the large prostate group and
31.2 cc (range: 17.2 cc to 39.9 cc) in the small prostate
group. None of the patients experienced major complica-
tions, including massive rectal bleeding or infection. 
Table 2 shows the VAS pain scores and the statistical
analysis of the VAS scores for comparing the large and
small prostate groups. The mean VAS scores during
periprostatic neurovascular bundle block, during biopsy
and 20 minutes after biopsy were 4.70  1.61, 3.15 
2.44, and 1.05  1.51, respectively. In the large prostate
group, the mean pain scores of VAS 1, 2 and 3 were 4.75
1.76, 3.51  2.76 and 1.29  1.70, respectively,
whereas in the small prostate group, the mean pain scores
were 4.66  1.46, 2.77  2.03 and 0.80  1.26, respec-
tively. Although there was no statistical difference
between the two groups during neurovascular bundle
block (VAS 1), the patients with a large prostate felt more
pain during biopsy (p = 0.045) and 20 minutes after biopsy
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Fig. 1. Ultrasonographic image of the anesthetic injection site
during periprostatic neurovascular bundle block. Arrow indicates
the site of lidocaine injection (P; prostate).(p = 0.049) (Table 2). 
DISCUSSION
Transrectal ultrasound guided prostate biopsy is an
essential diagnostic modality for making the preoperative
diagnosis of patients with a suspected malignancy.
Unfortunately, patients generally experience significant
pain during the procedure. Irani et al. reported that a
significant proportion of patients who underwent TRUS
guided prostatic biopsy felt pain, and biopsy should be
accompanied by some form of anesthesia (5). Moreover,
because of the patient’s fear of a potential diagnosis of
cancer and also fear of using the anal route, and too the
fact that the examined organ is part of the male sexual
system, the pain experienced during TRUS guided prostate
biopsy may induce vasovagal episodes in up to 5.3% of
the men (3, 6 8).
Given the demand for an increasing number of biopsies,
investigators are now showing an increased interest in the
risk factors for experiencing pain during TRUS guided
prostate biopsy. Identifying these risk factors is important
in terms of selecting those subgroups of patients who may
benefit from anesthesia or drugs. However, few of the risk
factors for pain have been established. A younger age,
anxiety, the number of cores taken and repeat biopsy
appear to be the risk factors of a painful biopsy (3, 4, 9
13). 
To the best of our knowledge, few studies have accessed
the relationship between prostate volume and biopsy pain.
According to recent reports, higher prostate volumes do
not necessarily increase the pain associated with the
procedure (3, 4). 
Bastide et al. performed a prospective study to identify
the risk factors of pain during prostate biopsy. According
to their report, among the six factors they studied (age,
prostate volume, number of cores, previous biopsy and
location of the first core), only the first core location
influenced the pain (3). However, their VAS was obtained
only once by employing an immediate postbiopsy
questionnaire.
In this study, we also divided the patients into two
groups according to their prostate volume with a cutoff
value of 40 cc, which was based on the criterion of a
previous study by Bastide et al. (3). 
However, the results of the present prospective compar-
ative study, in which number of cores, the presence or
absence of a previous history of biopsy and the location of
the first core were controlled and the patients’ mean age
showed equal variances between the two groups, showed
that patients with a larger prostate experienced more pain
during the TRUS guided prostate biopsy. There was
positive correlation between the prostate volume and pain
with statistical significance during and 20 minutes after
biopsy. 
Pain associated with the prostate predominantly arises in
the prostatic capsule or stroma; these are structures richly
innervated with autonomic fibers. Innervation of the
prostate is derived from the caudal roots of S2 to S5 and
also from the sympathetic chain via the presacral and
hypogastric neural plexuses. Nerve fibers from these nerve
plexuses branch out in the prostatic plexus and then they
travel with the prostatic vascular pedicles. It is believed
that these posterolateral nerve fibers are the main nerve
Pain versus Prostate Volume during Transrectal Prostate Biopsy
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Table 1. Comparison of Age, PSA and the Prevalence of Cancer in the Two Study Groups (n = 71)
Mean and Standard Deviations
Large Prostate Group (n = 36) Small Prostate Group (n = 35)
p-value
Age (years) 68.0 ( 7.9) 64.0 ( 9.7) *0.42
PSA (ng/ml)  11.5 ( 9.7) 11.0 ( 27.2) *0.92
Number of patients with cancer 12  16 *0.77
Note. *: p-values by the unpaired t-test,   : p-value by the Fisher’s exact test, PSA = prostate specific antigen
Table 2. Mean VAS Scores of the Two Study Groups
Mean and Standard Deviations
*p-value
Total Large Prostate Group (n = 36) Small Prostate Group (n = 35)
VAS 1 (during PNB) 4.70 ( 1.61) 4.75 ( 1.76) 4.66 ( 1.46) 0.613
VAS 2 (during biopsy) 3.15 ( 2.44) 3.51 ( 2.76) 2.77 ( 2.03) 0.045
VAS 3 (20 minutes after biopsy) 1.05 ( 1.51) 1.29 ( 1.70) 0.80 ( 1.26) 0.049
Note. *: p-values by the unpaired t-test between the large prostate group and the small prostate group, PNB = periprostatic neurovascular bundle blocksupply to the prostate (14 16). Issa et al. reported that
pain is generated by direct contact between these nerves
and the needle as it passes through the prostate (6). 
Based on these considerations, some urologists have
attempted periprostatic neurovascular bundle block before
prostate biopsy, and many investigators have shown that
local anesthesia is effective for reducing patient discomfort
(14, 17 19).
We presume that a more sparsely distributed periprosta-
tic neurovascular bundle and the reduced effectiveness of
the locally injected lidocaine to the sparsely distributed
nerve fibers in a larger prostate may contribute to the
positive correlation found between prostate volumes and
pain in our series, although any histological investigation
about the difference in distribution of the periprostatic
neurovascular bundle between large and small prostates
has not been reported. There may be other contributing
factors such as more severe anal pain or the pain from
stimulation of the prostate is generalized by manipulation
of probe during biopsy of the larger prostate. Further
studies about the distributions of periprostatic neurovascu-
lar bundles in correlation with the prostate volume and the
relation between the prostate volume and biopsy pain with
using varying amounts of injected lidocaine are required.
During periprostatic neurovascular bundle block, no
correlation was found between the prostate volume and
pain. We believe that pain during periprostatic neurovas-
cular bundle block is composed of pain associated with the
rectal wall when the probe is inserted through the rectum
and when the needle pierces the rectal wall, and it is not
reasonable to assume there is significant correlation
between prostate volume and pain during periprostatic
neurovascular bundle block. 
In the present study, periprostatic neurovascular bundle
block was the most painful step. Although which step is the
most painful during TRUS guided prostate biopsy has not
been universally confirmed, investigators have recently
reported the initial probe insertion with periprostatic
lidocaine instillation is more painful than the biopsy itself
when the biopsy is performed under periprostatic
neurovascular bundle block (20, 21). The present data
corroborates with the results of the previous studies. Even
though periprostatic neurovascular bundle block general-
izes the additional pain during procedure, it seems that
periprostatic neurovascular bundle block is effective to
reduce the overall pain during TRUS guided prostate
biopsy (14, 17 19).
There are several limitations in our study. First, we did
not consider some parameters, including the skill of the
operator that may affect the severity of the pain. Second,
although the study design was prospective, the way or
attitude in which the investigator handled the question-
naire with interviewing patients may have induced some
bias because the investigator knew the patients’ prostate
volume. So, a double blinded randomized study could
show more objective results. 
In conclusion, patients with larger prostate volumes were
found to experience higher degrees of pain during and
after TRUS guided prostate biopsy. This finding suggests
that additional analgesic strategies may be necessary for
performing TRUS guided prostate biopsies of larger
prostates.
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